Trial intelligence / Profile preview

Epinephrine-assisted continuous bladder irrigation after transurethral resection of the prostate

TCTR20260329001Phase 3Completed

Sponsor
Phramongkutklao Hospital Foundation
Start
Mar 2024
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, randomised trial of epinephrine in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Phramongkutklao Hospital Foundation. Started Mar 2024; status: completed.

02

Drugs

epinephrine
03

Conditions

benign prostatic hyperplasia (BPH)

Beyond the preview

Go deeper on TCTR20260329001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20260329001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call